Helbig et al., 1993 - Google Patents
Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigensHelbig et al., 1993
View PDF- Document ID
- 15273375237458161279
- Author
- Helbig M
- Frosch P
- Kern P
- Frosch M
- Publication year
- Publication venue
- Journal of Clinical Microbiology
External Links
Snippet
Two recombinant antigens of the larval stages of Echinococcus granulosus and Echinococcus multilocularis, termed EG55 and EM10, respectively, were applied for serodiagnosis and serological differentiation between parasitic infections caused by the …
- 239000000427 antigen 0 title abstract description 57
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Helbig et al. | Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigens | |
| Cornelissen et al. | Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease | |
| EP1179733A1 (en) | Compounds and methods for diagnosis of leishmaniasis | |
| JPH11502923A (en) | T. Compounds and methods for detecting CRUZI infection | |
| US6172192B1 (en) | Toxoplasma gondii antigen Tg20 | |
| Al-Yaman et al. | Isolation and partial characterization of species-specific and cross-reactive antigens of Echinococcus granulosus cyst fluid | |
| DE69619405T2 (en) | CONNECTIONS AND METHOD FOR DETECTING AND PREVENTING T.CRUZI INFECTIONS | |
| EP1141305B1 (en) | Chimeric gene encoding the antigenic determinants of four proteins of l. infantum | |
| Ownby et al. | Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family Crotalidae | |
| Ellis et al. | Leishmania: amastigotes synthesize conserved secretory acid phosphatases during human infection | |
| US8227584B2 (en) | Ostertagia vaccine | |
| US6187310B1 (en) | Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family | |
| US6525186B2 (en) | Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained | |
| US20020081312A1 (en) | Recombinant cryptosporidium parvum antigen and detection of antibodies thereto | |
| Frosch | Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigen | |
| Makarova et al. | Serological differentiation of acute and chronic schistosomiasis using Schistosoma mansoni recombinant protein RP26 | |
| US5578453A (en) | Cloning and expression of toxoplasma antigens and use of recombinant antigens | |
| US6710166B1 (en) | 41 kDa Cryptosporidium parvum oocyst wall protein | |
| US5456911A (en) | Synthetic malarial antigens and uses thereof | |
| AU710439B2 (en) | Recombinant 170 KD subunit lectin of Entamoeba histolytica and methods of use | |
| Haynes et al. | Purification and characterization of a 93 kDa Aspergillus fumigatus antigen with diagnostic potential | |
| US5422428A (en) | Immunization against babesiosis using purified surface antigens of Babesia bigemina and similar immunogens | |
| AU684009B2 (en) | Peptides for diagnostics | |
| Govaerts et al. | Characterisation of the 33 kDa piroplasm surface antigen of Theileria orientalis/sergenti/buffeli isolates from West Java, Indonesia | |
| AU659094B2 (en) | Cloning and expression of toxoplasma antigens and use of recombinant antigens |